|
Status |
Public on Mar 27, 2018 |
Title |
Inhibitors of LSD1 target demethylase-independent activity to induce differentiation in acute myeloid leukemia [anti-H3K9 ac, anti-H3K27, RCOR1, SPI1, and MLL4 ChIP-Seq] |
Organism |
Homo sapiens |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
To determine whether changes in histone modifications directly correlate with changes in transcription, THP1 AML cells were treated with a potent and selective LSD1 inhibitor (OG86, 250nM) and then subjected to concomitant RNA sequencing (RNAseq) and ChIP sequencing (ChIPseq) for histone acetylation modifications, RCOR1, SPI1 and MLL4.
|
|
|
Overall design |
THP1 AML cells were treated with 250nM OG86 or DMSO vehicle for 24 hours in RPMI with 10% fetal bovine serum.
|
|
|
Contributor(s) |
Somervaille T |
Citation(s) |
29590629 |
Submission date |
Mar 20, 2018 |
Last update date |
Mar 26, 2019 |
Contact name |
Tim C Somervaille |
E-mail(s) |
tim.somervaille@cruk.manchester.ac.uk
|
Organization name |
Cancer Research UK Manchester Institute
|
Lab |
Leukaemia Biology Laboratory
|
Street address |
Wilmslow Road
|
City |
Manchester |
State/province |
Lancashire |
ZIP/Postal code |
M20 4BX |
Country |
United Kingdom |
|
|
Platforms (1) |
GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
Samples (10)
|
|
This SubSeries is part of SuperSeries: |
GSE63222 |
Inhibitors of LSD1 target demethylase-independent activity to induce differentiation in acute myeloid leukemia |
|
Relations |
BioProject |
PRJNA439261 |
SRA |
SRP136095 |